RL
76
-2
CMS
58
-2
HSY
37
2
GLW
65
4
HPQ
59
14
MHK
53
-9
MMM
63
-6
V
36
-4
AMP
69
3
ADM
48
-3
DAL
74
-2
LEN
38
-3
PHM
59
7
CF
48
3
CCL
55
-2
AVGO
26
-2
TAP
29
-5
KHC
25
-4
MAR
65
-9
KMI
63
6
RL
76
-2
CMS
58
-2
HSY
37
2
GLW
65
4
HPQ
59
14
MHK
53
-9
MMM
63
-6
V
36
-4
AMP
69
3
ADM
48
-3
DAL
74
-2
LEN
38
-3
PHM
59
7
CF
48
3
CCL
55
-2
AVGO
26
-2
TAP
29
-5
KHC
25
-4
MAR
65
-9
KMI
63
6
Financhill
Back

EyePoint Pharmaceuticals, Inc. 10K Form

Buy
56

EYPT
EyePoint Pharmaceuticals, Inc.

Last Price:
$16.72
Seasonality Move:
16.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EYPT News And Ratings

See the #1 stock for the next 7 days that we like better than EYPT

EYPT Financial Statistics

Sales & Book Value

Annual Sales: $43.3M
Cash Flow: $-60.2M
Price / Cash Flow: 0
Annual Sales: $2.88
Price / Book: 6.91

Profitability

EPS (TTM): -2.99020
Net Income (TTM): $-205.8M
Gross Margin: $39.6M
Return on Equity: -79.15%
Return on Assets: -62.93%

EyePoint Pharmaceuticals, Inc. Earnings Forecast

Key EyePoint Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 19 years for EYPT is 91.42%.
  • The Selling, General & Administrative Expenses for EYPT have been equal to 121.30% of Gross Profit Margin.
  • The Research & Development expenses have been 307.18% of Revenue.
  • The Net Earning history of EYPT is -302.43% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 11 years.

EyePoint Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: EYPT
CUSIP: 30233G
Website: eyepointpharma.com

Debt

Debt-to-Equity Ratio: 0.12
Current Ratio: 7.18
Quick Ratio: 6.81

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EYPT Technical Analysis vs Fundamental Analysis

Buy
56
EyePoint Pharmaceuticals, Inc. (EYPT) is a Buy

Is EyePoint Pharmaceuticals, Inc. a Buy or a Sell?